FGFR4 and fatty liver disease: Taken together, our findings indicate that improvement in insulin sensitivity is not a direct consequence of hepatic FGFR4 silencing but may be mediated by circulating factors such as bile acids and gut hormones or be secondary to improved liver steatosis.